• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA 的癌基因谱作为尤文肉瘤治疗的新治疗靶点:综合综述。

Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review.

机构信息

The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children Hospital, Columbus, OH 43205, USA.

Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore 54590, Pakistan.

出版信息

Genes (Basel). 2023 Sep 23;14(10):1849. doi: 10.3390/genes14101849.

DOI:10.3390/genes14101849
PMID:37895198
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10606885/
Abstract

Ewing's sarcoma is a rare type of cancer that forms in bones and soft tissues in the body, affecting mostly children and young adults. Current treatments for ES are limited to chemotherapy and/or radiation, followed by surgery. Recently, microRNAs have shown favourable results as latent diagnostic and prognostic biomarkers in various cancers. Furthermore, microRNAs have shown to be a good therapeutic agent due to their involvement in the dysregulation of various molecular pathways linked to tumour progression, invasion, angiogenesis, and metastasis. In this review, comprehensive data mining was employed to explore various microRNAs that might have therapeutic potential as target molecules in the treatment of ES.

摘要

尤因氏肉瘤是一种罕见的癌症,形成于体内的骨骼和软组织中,主要影响儿童和青少年。目前 ES 的治疗方法仅限于化疗和/或放疗,然后是手术。最近,microRNAs 作为各种癌症中潜在的诊断和预后生物标志物,显示出良好的结果。此外,microRNAs 由于参与与肿瘤进展、侵袭、血管生成和转移相关的各种分子途径的失调,因此作为一种良好的治疗剂。在这篇综述中,采用了全面的数据挖掘来探索各种 microRNAs,它们可能具有治疗潜力,作为 ES 治疗的靶分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d0/10606885/35e110677fdd/genes-14-01849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d0/10606885/c7d603fa64c8/genes-14-01849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d0/10606885/35e110677fdd/genes-14-01849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d0/10606885/c7d603fa64c8/genes-14-01849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3d0/10606885/35e110677fdd/genes-14-01849-g002.jpg

相似文献

1
Oncomeric Profiles of microRNAs as New Therapeutic Targets for Treatment of Ewing's Sarcoma: A Composite Review.微小 RNA 的癌基因谱作为尤文肉瘤治疗的新治疗靶点:综合综述。
Genes (Basel). 2023 Sep 23;14(10):1849. doi: 10.3390/genes14101849.
2
TIPE1 inhibits the growth of Ewing's sarcoma cells by suppressing Wnt/β-catenin signaling.TIPE1 通过抑制 Wnt/β-catenin 信号通路抑制尤文肉瘤细胞的生长。
Clin Transl Oncol. 2023 May;25(5):1332-1339. doi: 10.1007/s12094-022-03030-3. Epub 2022 Dec 10.
3
MicroRNA‑34b promotes proliferation, migration and invasion of Ewing's sarcoma cells by downregulating Notch1.微小 RNA-34b 通过下调 Notch1 促进尤文肉瘤细胞的增殖、迁移和侵袭。
Mol Med Rep. 2018 Oct;18(4):3577-3588. doi: 10.3892/mmr.2018.9365. Epub 2018 Aug 9.
4
[Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma].[原发性皮肤尤因肉瘤:诊断与治疗的困境]
Ann Dermatol Venereol. 2011 May;138(5):395-8. doi: 10.1016/j.annder.2010.11.010. Epub 2010 Dec 24.
5
An integrated chemical biology approach identifies specific vulnerability of Ewing's sarcoma to combined inhibition of Aurora kinases A and B.一种综合的化学生物学方法确定了尤文肉瘤对 Aurora 激酶 A 和 B 联合抑制的特定脆弱性。
Mol Cancer Ther. 2011 Oct;10(10):1846-56. doi: 10.1158/1535-7163.MCT-11-0100. Epub 2011 Jul 18.
6
MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.miR-125b 通过抑制 PI3K/Akt 信号通路抑制尤文肉瘤的细胞生物学进展。
Cell Prolif. 2014 Apr;47(2):152-60. doi: 10.1111/cpr.12093. Epub 2014 Feb 12.
7
Arsenic trioxide inhibits Ewing's sarcoma cell invasiveness by targeting p38(MAPK) and c-Jun N-terminal kinase.三氧化二砷通过靶向 p38(MAPK)和 c-Jun N-末端激酶抑制尤文肉瘤细胞的侵袭性。
Anticancer Drugs. 2012 Jan;23(1):108-18. doi: 10.1097/CAD.0b013e32834bfd68.
8
Ewing's Sarcoma: An Analysis of miRNA Expression Profiles and Target Genes in Paraffin-Embedded Primary Tumor Tissue.尤因肉瘤:石蜡包埋的原发肿瘤组织中miRNA表达谱及靶基因分析
Int J Mol Sci. 2016 Apr 30;17(5):656. doi: 10.3390/ijms17050656.
9
Ewing's sarcoma: standard and experimental treatment options.尤因肉瘤:标准及实验性治疗方案
Curr Treat Options Oncol. 2009 Apr;10(1-2):126-40. doi: 10.1007/s11864-009-0104-6. Epub 2009 Jun 17.
10
Esophageal extraskeletal neoplasm Ewing's sarcoma: Case report.食管骨外肿瘤尤因肉瘤:病例报告
Int J Surg Case Rep. 2022 Aug;97:107399. doi: 10.1016/j.ijscr.2022.107399. Epub 2022 Jul 9.

引用本文的文献

1
The Double Life of microRNAs in Bone Sarcomas: Oncogenic Drivers and Tumor Suppressors.微小RNA在骨肉瘤中的双重作用:致癌驱动因素和肿瘤抑制因子
Int J Mol Sci. 2025 May 17;26(10):4814. doi: 10.3390/ijms26104814.
2
A Glimpse of Noncoding RNAs: Secondary Structure, Emerging Trends, and Potential Applications in Human Diseases.非编码 RNA 的一瞥:二级结构、新兴趋势及其在人类疾病中的潜在应用。
Methods Mol Biol. 2025;2867:331-344. doi: 10.1007/978-1-0716-4196-5_19.

本文引用的文献

1
Extraskeletal Ewing's sarcoma of the mediastinum: Case report.纵隔骨外尤文肉瘤:病例报告
Front Oncol. 2023 Jan 26;13:1074378. doi: 10.3389/fonc.2023.1074378. eCollection 2023.
2
Exploiting the Stemness and Chemoresistance Transcriptome of Ewing Sarcoma to Identify Candidate Therapeutic Targets and Drug-Repurposing Candidates.利用尤因肉瘤的干性和化疗抗性转录组来鉴定候选治疗靶点和药物再利用候选物。
Cancers (Basel). 2023 Jan 26;15(3):769. doi: 10.3390/cancers15030769.
3
Non-coding RNAs in human health and disease: potential function as biomarkers and therapeutic targets.
非编码 RNA 在人类健康与疾病中的作用:作为生物标志物和治疗靶点的潜在功能。
Funct Integr Genomics. 2023 Jan 10;23(1):33. doi: 10.1007/s10142-022-00947-4.
4
Exploration of Flavonoids as Lead Compounds against Ewing Sarcoma through Molecular Docking, Pharmacogenomics Analysis, and Molecular Dynamics Simulations.黄酮类化合物作为针对尤文肉瘤的先导化合物的探索:通过分子对接、药物基因组学分析和分子动力学模拟。
Molecules. 2023 Jan 3;28(1):414. doi: 10.3390/molecules28010414.
5
MicroRNAs and Long Non-coding RNAs as Novel Targets in Anti-cancer Drug Development.MicroRNAs 和长链非编码 RNA 作为抗癌药物开发的新靶点。
Curr Pharm Biotechnol. 2023;24(7):913-925. doi: 10.2174/1389201023666220803150431.
6
Prediction of Site Directed miRNAs as Key Players of Transcriptional Regulators Against Influenza C Virus Infection Through Computational Approaches.通过计算方法预测位点定向微小RNA作为转录调节因子对抗丙型流感病毒感染的关键参与者。
Front Mol Biosci. 2022 Apr 8;9:866072. doi: 10.3389/fmolb.2022.866072. eCollection 2022.
7
Zooming in on Long Non-Coding RNAs in Ewing Sarcoma Pathogenesis.聚焦尤文肉瘤发病机制中的长链非编码 RNA。
Cells. 2022 Apr 8;11(8):1267. doi: 10.3390/cells11081267.
8
miR-214-3p Is Commonly Downregulated by EWS-FLI1 and by CD99 and Its Restoration Limits Ewing Sarcoma Aggressiveness.miR-214-3p通常被EWS-FLI1和CD99下调,其恢复可限制尤因肉瘤的侵袭性。
Cancers (Basel). 2022 Mar 30;14(7):1762. doi: 10.3390/cancers14071762.
9
C-C Chemokine Receptor 7 in Cancer.C-C 趋化因子受体 7 在癌症中的作用。
Cells. 2022 Feb 14;11(4):656. doi: 10.3390/cells11040656.
10
Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma.miR-34 家族成员在抑制肺鳞癌细胞中的不同作用。
Biomed Pharmacother. 2021 Oct;142:111967. doi: 10.1016/j.biopha.2021.111967. Epub 2021 Aug 30.